Health

Eyeglasses may be ‘protective factor’ against coronavirus, researchers say

A new study by Chinese researchers suggests that people who wear eyeglasses for extended daily periods may be less susceptible to COVID-19.

While the main route of infection for coronavirus is believed to be through respiratory droplets from coughs, sneezes and talking, previous research amid the pandemic has pointed to the human eye as another potential route of infection.

Researchers from The Second Affiliated Hospital of Nanchang University in China, among other hospitals in China, published their findings in JAMA Ophthalmology on Wednesday.

A new study by Chinese researchers suggests that people who wear eyeglasses for extended daily periods may be less susceptible to COVID-19. (iStock)

CORONAVIRUS LINGERED IN WOMAN’S EYES LONG AFTER IT CLEARED FROM HER NOSE, STUDY REVEALED

“According to reports published in recent years, the prevalence of myopia [or nearsightedness] in China is now more than 80% of the population,” study authors wrote. “Wearing of eyeglasses is common among Chinese individuals of all ages. However, since the outbreak of COVID-19 in Wuhan in December 2019, we observed that few patients with eyeglasses were admitted in the hospital ward.”

To examine the association between wearing eyeglasses and COVID-19 infection, researchers conducted a cohort study involving 276 patients infected with the virus and admitted to the hospital from late January to March 13.

The median age was 51 and most of the patients were moderately ill with COVID-19, while 5% were severely ill.

Thirty patients (11%) wore eyeglasses, which included 16 cases of myopia, or 5.8% (median age 33 years), and 14 cases of presbyopia (loss of focus on nearby objects). None of the patients wore contacts or had refractive surgery.

FAUCI SUGGESTS GOOGLES, EYE SHIELD FOR BETTER PROTECTION AGAINST CORONAVIRUS

Thirty patients (11%) wore eyeglasses, which included 16 cases of myopia, or 5.8%. (iStock)

Using data from a previous survey, researchers said the average rate of nearsightedness among students ages 7 to 22 in the Hubei province in 1985 was nearly 32%. Now, those students are aged 42 to 57, which the researchers said was close to the median age of patients involved in the study.

“The myopia rate of 31.5% is higher than the 5.8% among our patients with COVID-19,” they wrote, hypothesizing that eyeglasses at least discourage wearers from touching their eyes and potentially transferring the virus.

“For daily wearers of eyeglasses, who usually wear eyeglasses on social occasions, wearing eyeglasses may become a protective factor, reducing the risk of virus transfer to the eyes and leading to long-term daily wearers of eyeglasses being rarely infected with COVID-19,” they wrote.

Researchers said the results from the limited sample size need to be confirmed through large-sample studies. Also, information on the current proportion of local eyeglass wearers and the myopia rate was said to have been “lacking and partly affected the integrity and validity of [the] data.”

They concluded that while existing guidelines do raise caution over eye infections, most people ignore these recommendations and focus on wearing masks and isolating at home instead.

“These findings suggest that the eye may be an important infection route for COVID-19, and more attention should be paid to preventive measures such as frequent hand washing and avoiding touching the eyes,” authors concluded.

CLICK HERE FOR THE FOX NEWS APP

Coronavirus isolation killing thousands of Alzheimer’s patients

Some 13,200 more people than usual have died from dementia since March, and health care professionals are placing much of the blame on isolation intended to prevent the spread of COVID-19.

According to a new report in The Washington Post, analysis of federal data from the Centers for Disease Control and Prevention reveals that more than 134,2000 people have passed away from diseases like Alzheimer’s since the coronavirus pandemic gripped the nation.

Dr. William Burke goes over a PET brain scan Tuesday, Aug. 14, 2018, at Banner Alzheimers Institute in Phoenix. (AP Photo/Matt York)

Social and mental stimulation both play a critical role in slowing dementia, and doctors have reported increased backsliding in patients who had been stable for years.

The rapid deterioration of dementia made a man in Indianapolis swallow food the wrong way, which led to a lung infection and his eventual death. A Bostonian woman became so atrophied and frail that a slight fall sent her to the hospital multiple times. Others have been struggling with severe weight loss.

Although only a tiny portion of the U.S. population resides in senior care facilities, nursing home deaths have accounted for around 40% of U.S. deaths from COVID-19.

University of Pennsylvania Alzheimer’s specialist Dr. Jason Karlawish told The Post that interaction with family is crucial.

“Families fill in a lot of gaps at nursing homes. They do much of the feeding and bathing. They advocate and communicate,” he said. “If you think of Alzheimer’s as a disability, family members are almost like a cognitive wheelchair for patients who have lost part of their mind. They’re essential.”

Georgia resident Dan Goerke, 61, told The Post that he had watched his 63-year-old wife, Denise, decline dramatically and pleaded with Republican Gov. Brian Kemp to rescind emergency rules putting facilities on lockdown.

This month, Florida and Arizona said they want to reopen nursing homes but have yet to explain how they will do so safely.

CLICK HERE FOR THE FOX NEWS APP

Goerke used to visit Denise seven days a week and they had been together for 23 years. The last time he heard her laugh was four months ago. Now, Denise is no longer able to speak to him.

“It’s like we as a country just don’t care anymore about older people,” he said. “We’ve written them off.”

Hundreds possibly exposed to coronavirus after visiting chiropractic office in Washington state

Nearly 300 patients were possibly exposed to the novel coronavirus in Clark County, Wash., after visiting a chiropractic office last week.

At least 14 employees were also potentially exposed, according to public health officials in Clark County. An employee at Chiro One Wellness Center in Salmon Creek tested positive for COVID-19 and was potentially contagious over a course of four days while working last week, according to the statement provided to Fox News from Clark County public health officials.

“All patients who visited the office Sept. 8, Sept. 9, Sept.10, and Sept.11 are considered close contacts who are at risk of contracting COVID-19,” the statement said.

Patients who attended the facility during that period were considered close contacts to the individual infected with COVID-19 and were told to quarantine immediately, officials said.

N95 MASKS USED AGAINST CORONAVIRUS CAN BE DECONTAMINATED WITH RICE COOKER: STUDY

“Public Health recommends all close contacts call their health care providers and request testing for COVID-19, even if they do not have symptoms. Close contacts should quarantine for 14 days, regardless of the test result. Anyone who develops symptoms during the 14-day quarantine, even if they tested negative earlier, should be tested for COVID-19,” the statement read.

According to public health officials in Clark County, an employee at a Chiropractic Office in Salmon Creek tested positive for COVID-19 and potentially exposed 300 patients to coronavirus and 14 employees
(iStock)

Patients who visited other Chiro One locations and the Salmon Creek office on other days do not need to quarantine as they were not exposed, the health officials noted in the release.

CORONAVIRUS PATIENTS USING UNIQUE PHYSICAL THERAPY TREATMENT TO BREATHE EASIER DURING RECOVERY

Chiro One Wellness Center was said to be working with public health officials and provided names and contact information of patients who were exposed. Public health officials said it could take several days to notify the hundreds of exposed patients, noting that individuals potentially exposed should self-quarantine immediately and not wait to be notified by health officials.

Symptoms of COVID-19 may include shortness of breath, cough, fever, chills, muscle ache, sore throat, headache and new loss of taste or smell, and these symptoms may occur up to 14 days after exposure to the virus, per the statement.

Over half of coronavirus-infected pregnant women showed no symptoms, CDC report says

While data is limited around birth outcomes and COVID-19, two new federal reports found that more than half of pregnant women infected with the virus were asymptomatic, or showed no symptoms.

The Centers for Disease Control and Prevention (CDC) on Wednesday published an early release for two reports relating to pregnancy and COVID-19.

One report found that among 598 hospitalized pregnant women with COVID-19, 55% were asymptomatic at admission.

“Testing policies based on the presence of symptoms might miss many SARS-CoV-2 infections during pregnancy,” said the CDC report.

TEXAS NEWBORN CONTRACTED CORONAVIRUS WHILE IN MOTHER’S WOMB: REPORT

The CDC advised pregnant women to avoid close contact with infected individuals and maintain six feet apart from non-household members, in addition to general COVID-19 preventative measures like wearing masks and practicing hand hygiene.
(iStock)

TRUMP REFUTES CDC’S REDFIELD VACCINE TIMELINE: ‘I BELIEVE HE WAS CONFUSED’

In the same study, around 16% of 272 pregnant women who showed symptoms for the virus needed intensive care, while nearly 9% underwent invasive mechanical ventilation and two women died.

None of these outcomes occurred among asymptomatic pregnant women, the CDC reported.

The most commonly reported symptoms were fever or chills and cough.

Both symptomatic and asymptomatic women experienced pregnancy losses, which accounted for around 2% of pregnancies.

It was also noted that preterm births among symptomatic women were approximately three times more frequent than among asymptomatic cases; 23% vs, 8%, respectively.

A second CDC report published Wednesday found an even higher rate of asymptomatic cases among pregnant women admitted for obstetric reasons at 81% or 50 of 62 women. Approximately 30% of pregnant women hospitalized for COVID-19 needed intensive care, 14% required mechanical ventilation and one woman died from the virus, according to the agency’s report.

CORONAVIRUS FACE MASKS HAVE INCREASED BOTOX DEMAND, PLASTIC SURGEON SAYS

Prepregnancy obesity and gestational diabetes were also found in higher prevalence among expectant women hospitalized for COVID-19 illness compared to those admitted for obstretic reasons, like delivery.

Preterm delivery prevalence (15.1% overall and 12.2% among live births) was noted to be “nearly 70% higher than baseline rates in VSD during the study period,” and stillbirth prevalence (3.2%) was “more than four times higher among women with SARS-CoV-2 than the baseline rate in VSD during the study period (0.6%).” VSD refers to data from the Vaccine Safety Datalink surveillance system conducted between March and May 30.

The CDC advised pregnant women to avoid close contact with infected individuals and maintain six feet apart from non-household members, in addition to following general COVID-19 preventative measures like wearing masks and practicing hand hygiene. The agency also advised testing babies born to COVID-19 patients and isolating these moms and their newborns apart from other hospitalized mothers and newborns.

CLICK HERE FOR THE FOX NEWS APP

Coronavirus may help researchers in fighting cancer, according to scientist

Coronavirus may have a silver lining, according to a study by a scientist at Dalhousie University. Dr. Shashi Gujar, with the department of pathology at Dal, along with colleagues in the United States, Denmark, France, Germany, and India, is studying if the immune response against SARS-CoV-2, the virus that causes COVID-19, could be repurposed to fight cancer using the immune system, a news release on the Dalhousie University website stated.

ARE YOU PROTECTED FROM CORONAVIRUS IF YOU’VE BATTLED THE COMMON COLD?

The body’s immune system detects foreign viruses and bacteria as threats but it does not do this to cancer, the release stated. Dr. Gujar explored if viruses like coronavirus can play a role as the next generation of cancer immunotherapy, according to his published report in the journal OncoImmunology

Dr. Shashi Gujar, with a group of international collaborators, is studying if the immune response against SARS-CoV-2, the virus that causes COVID-19, could be repurposed to fight cancer using the immune system
courtesy: iStock

“We’ve figured out how to trick your coronavirus-specific T cells to think that your cancer is infected by the virus,” Dr. Gujar said in the release. “The key is to do this without using the virus or actually causing the real infection.”

The release explained that when a person contracts SARS-CoV-2, the immune system recognizes the virus and “T cells” activate and act in a specific manner to kill only cells harboring the virus, the release explained.

CORONAVIRUS: COULD YOUR BODY ALREADY HAVE CELLS THAT RECOGNIZE AND FIGHT IT?

Vaccines currently being tested worldwide have demonstrated a similar ability to trigger these coronavirus-specific T cells, the report stated.

Experts have explained to Fox News that T cells have “memory cells” that are retained in the body after a person fights an infection. “The immune system remembers what it learned about how to protect the body against that disease,” the CDC website states. The “memory cells” will act as an alarm and help the immune system identify and produce antibodies to attack the foreign virus or other germs if it enters the body again, according to the federal health agency.

CLICK HERE FOR COMPLETE CORONAVIRUS COVERAGE

The authors said in the study release that coronavirus-specific T cells can search for the SARs-CoV-2 virus in the body, and destroy regions where the virus replicates and help the body recover from a COVID-19 infection.

The team of scientists are trying to get the T cells to attack the tumors by getting the cancer cells to express the same identifying markers as coronavirus-virus harboring cells, and thereby becoming targets of the coronavirus fighting T-cells, the release explained.

CLICK HERE TO GET THE FOX NEWS APP

“Once we know it works, this immunotherapy will actually be a straightforward process and may be something we’ll be able to start using on patients sooner rather than later. This is a highly novel and practical strategy to harness virus-specific T cells against various types of cancers. That’s what makes it so exciting.”

The coronavirus-specific cells can potentially be found in millions of people globally due to infection or a vaccine, making this type of cancer immunotherapy useful for a worldwide population, the release said.

The release also said the international group of scientists alongside Dr. Gujar are currently testing coronavirus-specific tags that occur in different populations. They then plan to make a “cocktail of these tags” to treat cancer in clinics throughout the world.

What to know about fall allergies and how to treat them

Summer is ending and fall is just around the corner, meaning days of cooler weather, vibrantly colored leaves and cozy sweaters are ahead. But the start of fall also means unwanted seasonal allergies, with symptoms sometimes presenting similarly to the novel coronavirus (here’s how to tell the difference between the two).

Read on for a look at what to know about fall allergies and ways to treat them.

CORONAVIRUS SYMPTOMS VS. ALLERGIES: HOW TO KNOW THE DIFFERENCE AS SCHOOL YEAR BEGINS

Common fall allergies to be wary of

Beware of ragweed, mold spores and dust mites in the fall, one expert advised.

“At this time of year, the predominant pollen in the air is ragweed and many people are suffering from nasal and ocular symptoms, including sneezing, congestion, runny nose and red, watery itchy eyes. Ragweed plants will continue to pollinate until the first frost, which usually occurs in October,” Dr. Susan Schuval, chief of the Division of Pediatric Allergy/Immunology at Stony Brook Children’s Hospital in New York, told Fox News in an email.

But ragweed isn’t the only allergen to worry about, as fall “is also the time of year when mold spores are in the air,” she said.

“This can be a problem when the leaves accumulate on the ground or on dry windy days,” said Schuval.

“Most COVID infections do not present with significant sneezing and itchy eyes. This is another way to differentiate between COVID and allergy symptoms,” one expert told Fox News.
(iStock)

Dust mites, too, can cause issues for fall allergy sufferers.

“Although dust mites are found in the house all through the year, people usually become symptomatic when they start spending more time indoors and the heat goes on in the house. Dust mites exposure occurs predominantly in the bedroom. Dust mite-allergic patients are advised to keep stuffed animals off the bed, wash bedding weekly in hot water, keep carpets clean, to avoid over humidification, and to encase pillows in hypoallergenic covers,” she advised.

How are fall allergies different from spring allergies?

“The symptoms remain the same, however, the environmental triggers are different in the spring; common allergens are tree pollen and grass. In the fall, its weeds such as ragweed. Many individuals are allergic to multiple things that can affect them year-round if they stay indoors, [which is] generally dust mites, pet dander, molds and cockroaches,” said Dr. Alfred Iloreta, an otolaryngologist at the Mount Sinai Hospital in New York, to Fox News.

How can I treat fall allergies?

“There are a number of medications to treat environmental allergies. These include antihistamines, nasal sprays and eyedrops,” said Schuval. “Allergy immunotherapy (allergy shots) may be indicated for patients who do not respond to pharmacotherapy. Evaluation by an allergist is always helpful to determine the patient’s exact allergic triggers and to individualize therapy.”

What are common allergy symptoms, and how are they similar to or different from those associated with COVID-19?

“In the fall, respiratory viral infections also become more prevalent when children go back to school and people spend time indoors. Patients with viral infections usually have fever along with respiratory symptoms,” said Schuval.

“This fall and winter, COVID-19 infection will also be a concern in people presenting with fever and respiratory symptoms. Although cough and nasal symptoms may be seen in both hay fever and COVID-19 infection, fever, body aches and severity of illness would be more indicative of COVID-19 infection. Evaluation by a physician may be needed to differentiate between the two conditions,” she added.

Iloreta echoed Schuval, warning that muscle aches, fevers and chills are common with COVID-19.

PRELIMINARY STUDY INVESTIGATES HOW CORONAVIRUS PARTICLES MAY TRAVEL IN CLASSROOMS, INDOOR AREAS

“COVID-19 infections are viral infections and will typically present with muscle aches, fevers, chills, and specifically for COVID-19, we are seeing that loss of taste and smell, as well as GI upset such as nausea, diarrhea or vomiting, will present,” Iloreta said, noting these symptoms “are not common symptoms of environmental allergies.”

“Most COVID infections do not present with significant sneezing and itchy eyes. This is another way to differentiate between COVID and allergy symptoms,” he added.

Coronavirus vaccine likely to be generally available in 2021, CDC director says

Dr. Robert Redfield, director for the Centers for Disease Control and Prevention (CDC), said a coronavirus vaccine may be generally available to the American public by the late second quarter to the third quarter of 2021.

The comments came amid a Senate Appropriations Subcommittee hearing on Wednesday.

A COVID-19 vaccine could be generally available to the American public by the late second quarter to the third quarter of 2021, according to Dr. Robert Redfield, director of the CDC. (Photo by Kevin Dietsch-Pool/Getty Images)

CORONAVIRUS PEDIATRIC FATALITIES MOSTLY AMONG MINORITIES, THOSE WITH UNDERLYING CONDITIONS, CDC SAYS

Redfield said he thinks a vaccine will initially be available “sometime between November and December,” though in “very limited supply and it will have to be prioritized.”

The health director estimated about 80 million people in the country with comorbidities would likely get vaccinated first before the general public.

Dr. Bob Kadlec, assistant secretary for preparedness and response department with Health and Human Services, said “it’s possible” that the U.S. is within three to four weeks of getting a manufactured vaccine.

Kadlec added that some of the ongoing clinical trials for vaccine candidates will be “completed in October,” and will then await a decision from the Food and Drug Administration regarding safety and efficacy.

CLICK HERE FOR THE FOX NEWS APP

Coronavirus pediatric fatalities mostly among minorities, those with underlying conditions, CDC says

Less than 1% of coronavirus-related deaths were among Americans younger than 21, and minorities and those with underlying conditions accounted for the vast majority of lives lost, according to new data.

The Centers for Disease Control and Prevention (CDC) released findings on Tuesday of 121 coronavirus-related deaths (around 0.08% of all deaths) among U.S. kids reported to the health agency by July 31.

Though COVID-19 infections tend to run a milder course in younger populations, complications do happen, the agency said.

CORONAVIRUS-LINKED INFLAMMATORY CONDITION HOSPITALIZES 2 CHILDREN IN IDAHO

Of the 121 deaths, around 75% were among Hispanic, non-Hispanic Black, and non-Hispanic American Indian/Alaskan Native kids, even though these populations represent 41% of kids in the U.S.

This disproportionate representation echoes patterns among essential workers, the CDC said, and the agency pointed to disparities in social determinants of health (i.e. crowded living conditions, wealth and educational gaps) for the racial and ethnic disparities driving COVID-19 incidence and outcomes.

Also, 10% of the deaths were among infants and 70% were between ages 10 to 20. Further, the majority (75%) of the deaths were among youth with at least one underlying medical condition, while 25% were previously healthy.

Common health conditions involved lung issues (including asthma), obesity, developmental conditions and heart problems.

NEARLY 60 CORONAVIRUS TESTS UNDERGO PERFORMANCE CHECKS BY FDA

Also, 65% of the deaths happened after hospital admission, the CDC said.

The health agency acknowledged, among other limitations, that the number of reported deaths could be incomplete due to delays in reporting and incomplete testing and recognition of the deaths.

Given the data, the CDC said that kids, especially those of racial and ethnic minority groups at higher risk, need clear and consistent prevention messages. The CDC also emphasized the importance of follow-up on cases and exposure and documentation of underlying medical conditions and cause of death.

“Health departments, health providers, and community partners can mobilize to remove systemic barriers that contribute to health disparities,” the CDC concluded.

CLICK HERE FOR THE FOX NEWS APP

Transparency in coronavirus vaccine development will be key to gaining public trust, expert says

President Trump has suggested a coronavirus vaccine could be ready for approval in a “matter of weeks,” but there is plenty of skepticism among the general public about whether it will be safe and effective. An Associated Press poll conducted in May found that 20 percent of respondents would not get the vaccine, while a small poll conducted by WebMD in July found that 30 percent of the 1,000 participants said they were unsure if they would get it.

The expedited timeline and political climate surrounding COVID-19 has caused some to wonder whether corners have been cut in the race to get approved first, but recent events surrounding a vaccine candidate put forth by AstraZeneca should be taken as a sign that the U.S. is continuing to put patient safety at the forefront, Dr. John Whyte, chief medical officer at WebMD, told Fox News.

FEDERAL GOVERNMENT UNVEILS PLANS TO MAKE CORONAVIRUS VACCINE FREE FOR ALL AMERICANS

On Tuesday, a top FDA official confirmed that AstraZeneca’s COVID-19 vaccine trial was on hold in the U.S. and that the agency would investigate after a participant in the U.K. trial developed a serious side effect thought to be transverse myelitis. In the U.K. and elsewhere, the trials have already resumed, Reuters reported.

“The system is working because it was put on hold and identified,” Whyte said, adding that now is the time that companies and health agencies have to work together to be transparent with their data and information, which will help with overall public perception.

“[People] want a transparent process,” he said. “They want to be able to hear from scientific experts – explain to me how this was expedited and no corners were cut. People will be responsive to that.”

EXPERTS WORRY AS US VIRUS RESTRICTIONS ARE EASED OR VIOLATED

One of the reasons the process has been able to speed up, Whyte said, is because there is still so much virus out in the environment. With other typical vaccine timelines, by the time the candidate was ready for trial the virus being targeted had largely subsided, making it harder to find participants and controls.

On the other hand, once a vaccine is approved the public’s shifting attitudes toward the virus, which has become a focus of the 2020 presidential campaign, may present several hurdles when it comes to formulating a vaccination campaign.

“There’s no doubt physicians and health professionals are going to have challenges in getting people vaccinated when it comes to COVID, based on fear from what they hear in the news and it being expedited and political agendas,” he said.

NEARLY 60 CORONAVIRUS TESTS UNDERGO PERFORMANCE CHECKS BY FDA

“But what we haven’t done is look at the positive which is the innovation,” he said. “We had nothing in January – and here we are with multiple candidates – that’s a success, but we have to be transparent about it and we haven’t been.”

Whyte said it also will be vital for physicians to explain to patients – especially those in vulnerable populations – that the benefits of being vaccinated outweigh the risks of contracting COVID-19.

CLICK HERE FOR COMPLETE CORONAVIRUS COVERAGE

Another concern will be how to distribute it through the population, as struggles with annual flu vaccination supplies, and even COVID-19 testing kits, signal it may prove difficult. Targeting those most at-risk will be crucial, Whyte said, with a staggered approach in vaccinating the rest of the population likely to be most successful.

“It’s no easy task,” he said, “everyone can’t line up tomorrow at CVS.”

Coronavirus-linked inflammatory condition hospitalizes 2 children in Idaho

Two confirmed cases of coronavirus-associated Multisystem Inflammatory Syndrome in Children (MIS-C) in Idaho were reported this week.

Two children from the South Central Public Health District (SCPHD) have been diagnosed with the syndrome and were hospitalized, according to a news release provided to Fox News from St. Luke’s Health System and the SCPHD.

No other information has been released to protect the privacy of the children and their families, the release stated.

YOUNG CHILDREN WITH CORONAVIRUS MAY CARRY 10 TO 100 TIMES MORE OF VIRUS THAN ADULTS: STUDY

Health experts told Fox News that MIS-C is a rare condition that has affected some children and teenagers who have been exposed to COVID-19 infection or contracted the virus.

Children who develop MIS-C experience inflammation in several areas of the body, which may include the lungs, heart, brain, kidneys and other organs, according to the Centers for Disease Control and Prevention (CDC) and health experts who spoke to Fox News.

“We are concerned that these exceptionally serious cases are occurring. We are fortunate to have experienced pediatric subspecialists available in our community to care for these children and keep them and their families close to home,” Dr. Kenny Bramwell, medical director for St. Luke’s Children’s, said in the press release. “Please continue to be vigilant about preventive measures. They do make a difference.”

Idaho’s first suspected case was reported in August and then confirmed at a later time.

“We are seeing more and more young people contract and spread COVID-19. MIS-C is a complication from the disease that can cause serious health issues in our youngest Idahoans,” stated Tanis Maxwell, SCPHD epidemiologist, in the release. “Simple actions, like wearing a mask and social distancing, protect all of us. Including our children.”

CORONAVIRUS-LINKED HEART CONDITION BECOMES GROWING CONCERN FOR NCAA ATHLETES

Dr. Roberto Posada, a pediatric infectious disease control expert from Mount Sinai Hospital in New York City, previously told Fox News that MIS-C “occurs several weeks after the child was exposed to someone who had a coronavirus infection. Typically the child didn’t have symptoms of COVID-19 but does show antibodies when tested.”

According to health experts, this often occurs two to four weeks after a child has exposure to the novel coronavirus.

“It usually will present with high fever lasting several days, plus one or more the following: rash, red eyes, cracked or swollen lips, abdominal pain, vomiting or diarrhea,” Posada said at the time, adding that most kids recover from MIS-C.

MIS-C was first reported in the United States in May 2020. As of Sept. 3, the CDC reported 792 confirmed cases of MIS-C.

Health

Common fall allergies to be wary of

How are fall allergies different from spring allergies?

How can I treat fall allergies?

What are common allergy symptoms, and how are they similar to or different from those associated with COVID-19?

Footer

Public File Info